Search

CN

搜索
imgboxbg

Products

>
>
>
>
HemaSeq Human 248 Gene Mutation Detection Kit(NGS-for Illumina)
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part F_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part A_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part B_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part C_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part D_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part E_3504x2613
捕获法-全套_3700x2613

HemaSeq Human 248 Gene Mutation Detection Kit(NGS-for Illumina)

Product introduction Targeted-capture NGS technology is applied to detect 248 core genes related to myeloid hematological tumors (MPN/AML/MDS/CMML) simultaneously. SNV, Indel and splicing can be obtained in the 248 core target regions at one time.
Cat. No.:
S0918-S
Spec:
6 rxns/Kit(60 Tests)
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part F_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part A_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part B_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part C_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part D_3504x2613
HemaSeq人类248基因突变检测试剂盒(可逆末端终止测序法)-Part E_3504x2613
捕获法-全套_3700x2613
Product description
Parameters

 

Target Population:

 

 

Patients with suspected or confirmed myeloid hematological tumors such as AML, MDS, MPN, CMML, JMML.

 

 

Detection Range:

 

 

 

Related disease Number of genes Actionable results

MDS

118

Diagnosis typing
Prognosis judgment
Guiding therapy
MRD testing
Clonal evolution

MDS/MPN

41

MPN

78

AML

186

Genetic susceptibility

49

 

 

 

Advantages

 

 

1. Based on authoritative databases, professional guidelines, and the latest literature, it covers both common gene mutations used for clinical detection, and disease-related genes for clinical research as reported in the literature.


2. Targeted capturing probe design enables the detection of all point mutations and small fragment insertions/deletions in the CDS region.


3. The probe coverage reaches 99.3%, with a capture region of 1.02 M, suitable for deep sequencing and meeting clinical needs of 2000× detection.
 

 

 

 

Clinical Significance of Genes:

 

Clinical application

Gene example

Diagnosis and differential diagnosis

ANKRD26,APC,ASXL1,ATG2B,BCL10,BRCA1,BRCA2,CALR,CBL,CD95,CEBPA, CHEK2,CSF3R,DDX41,DNMT3A,EPCAM,ERBB3,ETNK1,ETV6,EZH2,FANCA,FA NCB,FANCC,FANCD2,FANCE,FANCF,FANCG,FANCI,FANCL,FANCM,GATA2.GS KIP,IDH1,IDH2IKZF2,IKZF3.

Prognosis evaluation ABL1,ASXL1,ASXL2,ATM,BCL10,BCOR,BLM,BRCC3,CCND3,CDKN2A,CEBPA,DNMT3A,ETV6EZH2FBXW7FGFR3FLT3,FOXP1.
Guiding therapy ABL1,ALK,BCL2,BCR,BRAF,CSF3R,FGFR3,FLT3,HRAS,IDHI,IDH2,JAK1,J AK2,JAK3,KITKRASMDM2METMPLNF1,NPM1.
Clinical research

ACTB,AF1O,ANKRD26,ARID1A,ARID1B,ARID2,ASXL3,ATRX,BAP1,BCL11 B,BCL3,BCL7A,BCR,BRD4,BTG1,CAD,CBFB,CBLB.CDKN1B,CHD2,CIITA, CMYA5,COL1A1,CPS1.CSMD1,CTCF,CUX1,DHX15,DICER1,DOT1L,DTX1,E BF1,EED,EGR1.

 

     

 

Gene List (only partial genes displayed)

 

 

 

ABL1

KIT

NFE2

PTPN11

GATA2

KRAS

ANKRD26

CSF3R

NOTCH1

RAD21

GNAS

SF1

ASXL1

CSMD1

NPM1

ROBO1

IDH1

SF3A1

ATM

CUX1

NRAS

ROBO2

IDH2

SF3B1

BCOR

DDX41

PDGFRA

RUNX1

IKZF1

SMC1A

BCORL1

DNMT3A

PHF6

SETBP1

JAK1

SMC3

BRAF

EP300

PIGA

ETV6

JAK2

SRP72

CALR

ETNK1

PRPF40B

EZH2

JAK3

SRSF2

CBL

MPL

PRPF8

FLT3

KMT2C

STAG2

CEBPA

NF1

PTEN

GATA1

KMT2D

SUZ12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ordering Information

 

 

Cat. No. Product Strength
S0918-S HemaSeq Human 248 Gene Mutation Detection Kit
(NGS-for Illumina)

6 rxns/Kit

(60 Tests)

 

Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table

Copyright:Wuhan Healthy Biotechnology Co., Ltd.